Anagnostics, Focusing on Integrated Sepsis Diagnostics Business, Eyes Opportunities in the EU, US | GenomeWeb

Anagnostics is planning to expand its sales and marketing activities in the EU as well as the US as it narrows its focus to its nascent integrated sepsis diagnostics business.

The St. Valentin, Austria-based company, which bills itself as the developer of the world's only cylindrical microarray, also offers a number of companion diagnostics, but it has chosen to seek partners to develop the market for those tests while it explores opportunities for its sepsis menu.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

Theresa May tries to reassure researchers about the UK's commitment to science, New Scientist reports.

In Science this week: new single-cell RNA sequencing technique to study proliferating cells, and more.

South African researchers uncover bone cancer in an ancient hominin ancestor.

English bulldogs suffer from low genetic diversity and might have to be outbred to improve their health, according to a new study.